Glutamic acid is an amino acid with an acidic side group. It works as a proton donor. Decarboxylation of glutamic acid results in the formation of GABA (γ aminobutyric acid), a potent neurotransmitter. Isotope labeled amino acids are required for the production of isotopically labeled proteins.
Spezifikationen
Synonyme
¹³C and ¹⁵N Labeled L-glutamic acid, Glu-¹³C₅,¹⁵N, (S)-2-Aminopentanedioic acid-¹³C₅,¹⁵N
Spezifikationen & Reinheit
≥98 atom% 13C,≥98 atom% 15N,≥95%
Storage
Room temperature
Aktionsart
ACTIVATOR
Reinheit
≥98 atom% 13C,≥98 atom% 15N,≥95%
Namen und Kennungen
Molekulargewicht
153.09
Erweiterte Daten
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemische und physikalische Eigenschaften
Schmelzpunkt (°C)
184-187° C
Sicherheit und Gefahren (GHS)
Sicherheitshinweise
P264:Wash hands [and …] thoroughly after handling.
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Bewertungen
Kundenbewertungen
Application Protocols
General, non-item-specific protocols leveraging L-Glutamic acid-13C5,15N. Optimize for your system and consult the CoA for enrichment values.
LC–MS/MS internal standard for glutamate quantitation (biofluids/cell extracts):
Prepare a 1–10 mM stock in water or 50 mM ammonium formate, pH ~3.5. Filter (0.22 µm). Store aliquots at −20 °C.
Spike samples with a fixed volume to achieve 1–10 µM final IS concentration.
Precipitate proteins with 3 volumes cold ACN/MeOH (1:1) containing 0.1% formic acid. Vortex, incubate on ice 10 min, centrifuge 15,000×g for 10 min.
Inject supernatant onto HILIC LC–MS/MS; quantify using isotope-dilution calibration.
13C/15N NMR metabolite tracing (cell culture):
Culture cells in medium where unlabeled glutamate is minimized; supplement with 2–5 mM 13C5,15N-glutamate or feed with labeled glutamine converting to glutamate in situ (depending on study design).
After defined pulse (e.g., 1–6 h) or steady-state, quench metabolism (cold 80% MeOH), extract, dry, and reconstitute in D2O or aqueous buffer for NMR.
Acquire 13C{1H} spectra and 1H–13C HSQC; analyze isotopomer distributions.
SPPS incorporation (residue-selective labeling):
Use the appropriately protected labeled derivative (e.g., Fmoc-L-Glu(OtBu)-OH, labeled at backbone/side-chain).
Couple under standard Fmoc protocols; verify incorporation by HRMS of crude/cleaved peptide.
Note: Concentrations and times are illustrative. Validate linearity, recovery, and matrix effects for your specific assay.
Biological Roles
General biological context for L-glutamate (applies equally to 13C/15N-labeled material in tracer studies):
Core metabolism:
Central node in nitrogen and carbon metabolism; interconverts with α-ketoglutarate via transaminases (e.g., GOT2/GOT1), linking amino acid catabolism to the TCA cycle.
Donor/acceptor of amino groups in biosynthesis (e.g., glutamate dehydrogenase, glutamine synthetase/glutaminase axis).
Neurochemistry (biochemical perspective, no clinical claims):
Major excitatory neurotransmitter in vertebrate CNS; participates in glutamate–glutamine cycling with astrocytes; uptake by EAAT transporters.
Biosynthetic roles:
Precursor to γ-aminobutyric acid (GABA) via glutamate decarboxylase (GAD);
Provides the γ-carboxyl in γ-glutamyl linkages (e.g., glutathione synthesis: γ-Glu–Cys–Gly).
Isotope tracing utility:
13C labeling resolves positional carbon incorporation in TCA intermediates (e.g., C2–C5 patterns in glutamate mirror α-ketoglutarate labeling);
15N monitors transamination and nitrogen flux into amino acids and nucleotides.
Compartmentation:
Mitochondrial–cytosolic shuttles (malate–aspartate) modulate glutamate/α-KG pools, observable via labeled isotopomers.
These roles underpin widespread use of L-Glutamic acid-13C5,15N in metabolic flux analysis, stable-isotope-resolved metabolomics (SIRM), and NMR/MS-based pathway mapping.
Buffer Applications
L-Glutamic acid itself is not a primary laboratory buffer of choice, but glutamic acid/glutamate conjugate pairs can provide buffering near the acidic range.
Practical buffering window (literature):
Around pKa2 ≈ 4.1 (γ-CO2H): Effective pH ~3.5–4.5 using glutamic acid/monosodium glutamate.
Around pKa1 ≈ 2.1: Niche applications at very low pH.
Example preparation (general guidance):
To make ~50 mM glutamate buffer at pH 4.1: Dissolve monosodium glutamate in water and titrate with HCl or glutamic acid to the target pH; verify ionic strength and compatibility with your assay.
Considerations:
Ionic strength and temperature influence pKa; verify pH under working conditions.
For enzymology or cell culture, more conventional buffers (acetate, citrate, phosphate, HEPES) typically provide better-defined properties.
Using the 13C5,15N-labeled material as the buffer component is generally not economical; employ unlabeled glutamate for buffering and reserve labeled compound for tracer/internal standard functions.
Conclusion: While chemically feasible, glutamate-based buffers are uncommon. For most applications involving this product, focus on its role as a tracer or quantitative internal standard rather than as a buffering agent.
Green Alternatives
This product is a solid amino acid used primarily as a tracer or internal standard rather than as a process solvent or bulk reagent. Green chemistry considerations focus on analytical method design and minimal waste.
Greener analytical choices (general guidance):
Prefer aqueous mobile phases with volatile, low-toxicity buffers (ammonium acetate/formate) for LC–MS over high-strength acetonitrile gradients when feasible.
For derivatization-free LC–MS of amino acids, hydrophilic interaction chromatography (HILIC) or mixed-mode columns can avoid silylation reagents (e.g., BSTFA, MTBSTFA) used in GC–MS.
Micro-scale protocols: Use microextraction and low-volume injection techniques to reduce solvent consumption while maintaining sensitivity.
Reusability: Where appropriate, standardize a single internal standard solution for multiple assays to minimize preparation waste; store aliquots to extend usable life.
Comparison (illustrative):
GC–MS with silylation vs LC–MS without derivatization:
Tradeoffs: Potentially lower chromatographic resolution for structural isomers; may require specialized columns and ion-pair avoidance.
Note: The sustainability profile of the isotopically labeled amino acid itself is largely determined by upstream isotope production and biosynthetic/chemical routes; end users can still improve greenness by solvent choice, miniaturization, and waste segregation.
Pharmaceutical Uses
No therapeutic claims are implied. The following relates to formulation/analysis contexts.
Excipient roles (general):
Amino acids, including glutamic acid and its salts, are used as pH adjusters, counter-ions, and stabilizers in parenteral and lyophilized formulations; they can modulate tonicity and prevent aggregation of biologics.
Monosodium glutamate has been explored as a bulking agent/cryoprotectant in lyophilization matrices (selection depends on target and compatibility).
Analytical/QC applications:
Isotopically labeled glutamate (13C5,15N) serves as a calibration/internal standard in LC–MS-based release testing for amino acid profiling and process-related impurity monitoring.
Employed in bioanalytical assays to quantify endogenous glutamate in biological matrices supporting PK/PD or biomarker studies.
Pharmacopeial status:
Unlabeled L-glutamic acid/monosodium glutamate appear in compendia (e.g., USP/EP) with defined quality tests; isotopically labeled variants are typically research-grade with supplier-specific specifications.
Process considerations:
For GMP environments, document isotopic enrichment, impurity profile, and residual solvents (if any) per batch CoA. Validate analytical methods for matrix effects and isotope interference.
Item-specific grade/purity for SKU L471828: Not specified; refer to CoA/Spec Sheet. Storage is room temperature per Product Data; verify excursion tolerances for your quality system.
Physical Properties
Item-specific specifications are not provided in the Product Data; consult the CoA/Spec Sheet for definitive values. Below are literature/computed properties for L-glutamic acid (free acid) to guide method development; isotopic enrichment minimally affects bulk physical properties.
Physical state/appearance: Not specified for this item; refer to CoA/Spec Sheet.
Melting point (literature, L-form): ~205–212 °C (decomp.)
Solubility (literature):
Water (25 °C): modest; reported ~3–4 g/100 mL for L-glutamic acid; solubility increases at low pH (fully protonated) or as monosodium salt (highly soluble)
Practically insoluble in most nonpolar organic solvents; sparingly soluble in ethanol/methanol; soluble in polar aprotic solvents only after salt formation/ion-pairing
pKa values (literature, 25 °C, ionic strength-dependent):
Density, refractive index: Not applicable to a crystalline solid; not commonly reported
Hygroscopicity: Generally low-to-moderate; can absorb moisture depending on form and milling; monitor for caking
Notes:
Isotope substitution (13C/15N) does not materially change pKa or solubility but increases exact mass: monoisotopic mass (13C5,15N) ≈ 153.066 Da (computed). Always calibrate MS methods accordingly.
Quality and Grades
Item-specific grade/purity: Not specified for this item; refer to CoA/Spec Sheet for assay, isotopic enrichment levels (atom % 13C/15N), residual solvents, and related impurities.
Interpretation and best practices (general for stable-isotope amino acids):
Isotopic enrichment:
Key quality attribute for this product class. Reported as atom % 13C at each carbon and atom % 15N at the nitrogen, plus overall chemical purity (% area by HPLC/UPLC).
High enrichment (e.g., ≥98 atom %) reduces spectral overlap and improves quantitation in NMR/MS tracer studies.
Chemical grade descriptors you may encounter (general definitions):
Research grade: Suitable for most analytical and synthesis applications; impurity limits defined by supplier’s internal specs.
Isotope tracer grade: Emphasizes isotopic and chemical purity; low levels of unlabeled isotopologues.
LC–MS grade: Low nonvolatile background; minimal inorganic salts; optimized for MS response and low adduct formation.
Stabilizers: Typically none required for amino acids; if present, should be disclosed on CoA. Avoid stabilizers for quantitative isotope-dilution workflows.
Identity/assay verification:
Recommended tests: 1H/13C NMR (qualitative), HRMS (exact mass of [M+H]+ ~154.074 for 13C5,15N species), enantiomeric purity by chiral HPLC, and water content by KF. Values for this specific item are Not specified; consult CoA.
Documentation: For regulated workflows, retain batch CoA and any isotopic distribution data (M, M−1, M+1, etc.) for method validation.
Reaction and Applications
Primary uses of L-Glutamic acid-13C5,15N are as a stable-isotope tracer and internal standard in metabolomics, fluxomics, and isotopically labeled synthesis.
Stable isotope tracing (general):
13C5 enables tracking of carbon flow through the TCA cycle, anaplerosis (e.g., via α-ketoglutarate), and the glutamate–glutamine shuttle. 15N labels transamination and nitrogen assimilation pathways.
Use as a 1:1 structural IS for endogenous glutamate quantitation in biofluids, cell extracts, or tissue homogenates; spiking at known concentration compensates for matrix effects and extraction losses.
Isotopically labeled synthesis:
Building block for preparing 13C/15N-labeled peptides and proteins via SPPS or cell-free expression; side-chain protection (e.g., OtBu) preserves γ-CO2H during coupling.
Derivatization chemistry for analysis:
GC–MS: Convert to TBDMS or MTBSTFA/TMS derivatives for volatility; retain isotopic integrity.
LC–MS: PITC (phenylisothiocyanate), AQC, or AccQ•Tag reagents for improved chromatographic behavior (if needed).
NMR notes:
13C labeling increases sensitivity for 13C spectra; J-couplings (1JCC, 1JCN) provide positional information. 15N labeling enhances HSQC/HMBC experiments.
Practical tips:
Prepare fresh aqueous stocks; avoid prolonged exposure to strong acid/base if positional scrambling is a concern.
Document exact isotopic enrichment from CoA to set correction matrices for natural-abundance and isotope-resolved data analysis.
Reaction Conditions
General conditions for common transformations involving glutamic acid or its protected derivatives (guidance; not item-specific specs):
Amide couplings (peptide bond formation):
Reagents: HATU or HBTU (3–5 equiv) with DIPEA (3–6 equiv) in DMF or NMP; or EDC·HCl (1.1–1.5 equiv) with Oxyma/HOBt in DMF.
Conditions: 0–25 °C, 0.5–4 h for SPPS; 2–16 h for solution phase. Typical stepwise SPPS couplings reach >95% conversion per cycle.
Ester formation/protection:
tBu esterification via acid-catalyzed protection (Boc chemistry) or via DCC/DIC with tert-butanol; benzyl esters via DCC/DMAP followed by hydrogenolysis (Pd/C, H2, rt–40 °C).
Deprotection:
Fmoc removal: 20% piperidine in DMF, 5–20 min cycles.
tBu removal: TFA/DCM (95:5), 0.5–2 h at rt; scavenge with TIS/water.
Benzyl removal: H2 (1–3 atm), Pd/C (5–10%), rt–40 °C, 2–8 h.
Decarboxylation/cyclization:
Pyroglutamate formation under heating or acid catalysis; control conditions to avoid unwanted cyclization in peptide work.
Oxidative deamination to α-ketoglutarate:
Enzymatic (GDH/NAD+); or chemical using mild oxidants under buffered conditions, useful for labeled standard preparation.
Analytical method conditions (illustrative):
LC–MS/MS quantitation:
Sample prep: Protein precipitation with MeOH/ACN (2–4× volume) containing internal standard; centrifuge; analyze supernatant.
Chromatography: HILIC or reversed-phase with ion-pair-free mobile phases; aqueous 5–20 mM ammonium formate/acetate, pH 3–5; gradient with ACN.
Detection: ESI(+) MRM, e.g., m/z 154→136/84 for 13C5,15N-glutamate (transitions depend on instrument optimization).
Always tailor conditions to the protected form in hand and verify isotopic integrity post-reaction.
Safety and Handling
GHS/SDS information:
Signal word, hazard statements, classification, pictograms: Not specified for this item; refer to the product SDS for authoritative safety data.
General hazard profile (contextual, literature): L-Glutamic acid is a naturally occurring amino acid with low acute toxicity. Dust may cause mechanical irritation of eyes/respiratory tract. Not known to be flammable or reactive under normal lab conditions.
Safe handling practices (general guidance):
PPE: Laboratory coat, safety glasses, and suitable gloves (e.g., nitrile). Use a dust mask/respirator if generating airborne particulate.
Engineering controls: Handle powders in a fume hood or ventilated enclosure to minimize inhalation of fines. Avoid creating dust clouds.
Incompatibilities: Strong oxidizers; strong bases/acids may cause decomposition or salt formation (not hazardous per se but alters material). Avoid mixing with nitrosating agents if amine nitrosation is a concern in specific processes.
Inhalation: Move to fresh air; seek medical attention if symptoms persist.
Skin/eye contact: Rinse with water for several minutes; remove contaminated clothing.
Ingestion: Rinse mouth with water; seek advice if large quantities are involved.
Spill/leak: Sweep up gently to avoid dust; collect in suitable container. Wash spill area with water.
Waste: Dispose in accordance with institutional and local regulations; stable isotopes do not pose radiological hazards.
Always defer to the SDS and institutional EHS guidance for definitive handling instructions.
Solvent Selection
As a zwitterionic amino acid, L-glutamic acid (13C5,15N) is best handled in aqueous or aqueous–buffered media. Choice of solvent depends on protonation state and downstream analysis (MS/NMR).
Polarity/miscibility (literature):
Highly polar; insoluble in nonpolar solvents. Practical solvents are water and water-rich mixtures.
Water solubility is modest for the free acid at neutral pH; solubility increases markedly as monosodium/disodium salts.
Practical options:
Water or buffer (pH 2–4): Enhances solubility near/below pKa2; useful for stock solutions when acid form is supplied.
Slightly basic aqueous media (pH 7.4–8.5): Improves dissolution via deprotonation of carboxyls; verify stability for your assay.
D2O or 90:10 H2O/D2O: For NMR; adjust pH* (uncorrected glass electrode in D2O) appropriately.
Aqueous-organic (e.g., H2O/MeOH ≤50%): Can aid dissolution and sterile filtration; avoid excessive organic if precipitate forms.
When to convert to salt:
Prepare monosodium glutamate in situ (1 equiv NaOH) for rapid dissolution and neutral pH applications; MS users should account for sodium adducts.
Compare to alternatives:
Glutamine is more soluble but undergoes deamidation; glutamate is more chemically stable in aqueous media over time.
Notes:
Filter sterilization (0.22 µm) is preferred over heat sterilization to avoid decomposition.
For LC–MS, use volatile buffers (ammonium acetate/formate, pH 3–6) to maintain ionization efficiency and minimize nonvolatile residue.
Storage and Reconstitution
Storage (item-specific from Product Data): Room temperature. Protect from excessive humidity; keep container tightly closed. For long-term analytical consistency, many users store working stocks at 2–8 °C or as frozen aliquots.
Shipped in: Not specified for this item; refer to CoA/Spec Sheet.
Reconstitution and stock preparation (general guidance):
Solvents: Water, dilute buffers (e.g., 10–50 mM ammonium formate/acetate, pH 3–6), or D2O for NMR. Adjust pH to 3–4 (or prepare monosodium salt) to facilitate dissolution.
Concentration: Prepare 1–100 mM stocks depending on application. Filter (0.22 µm) to ensure clarity for LC–MS.
Sterility: For cell culture/metabolic flux experiments, prepare under sterile conditions and filter sterilize; avoid heat sterilization.
Aliquoting: Dispense single-use aliquots to avoid repeated freeze–thaw cycles.
Stability:
Dry solid: Generally stable at ambient conditions away from moisture and light.
Aqueous solutions: Stable for days at 2–8 °C; for longer-term storage, freeze at −20 to −80 °C. Avoid prolonged exposure to strong acid/base that can promote side reactions (e.g., cyclization to pyroglutamate under harsh conditions).
Documentation: Record batch/lot and isotopic enrichment for traceability in quantitative workflows.
Always consult the product’s CoA/SDS for definitive storage constraints and compatibility.
Structure and Identity
Isotopically enriched L-glutamic acid labeled with five 13C and one 15N atoms; a chiral, α-amino dicarboxylic acid used as a stable-isotope tracer.
Item-specific identifiers from Product Data:
SKU: L471828
CAS: 202468-31-3
Storage conditions: Room temperature
Other identifiers (SMILES, InChIKey, CID): Not specified for this item; refer to CoA/Spec Sheet.
Literature/computed identity (for reference; not item-specific specifications):
Common name: L-Glutamic acid (uniformly 13C5,15N-labeled)
Molecular formula (isotopic): 13C5H9 15NO4 (literature/computed)
Average molecular weight: ~153.14 g/mol (computed from C5H9NO4 = 147.13 g/mol + 5×1.00335 + 1×0.99703)
Stereochemistry: L-configuration at the α-carbon (S absolute configuration by Cahn–Ingold–Prelog for L-amino acids)
Functional groups: α-amino (–NH2/–NH3+), α-carboxyl (–CO2H), γ-carboxyl side chain (–CH2–CH2–CO2H)
Representative isotopic SMILES (literature): NC@@HC(13CH)H with [15N] at the amino position; multiple equivalent encodings exist.
Structural description in words (general):
A five-carbon backbone bearing an α-amino group and two carboxylic acids; the side chain is –CH2–CH2–CO2H. In aqueous media near neutral pH it exists predominantly as a zwitterion (–NH3+ and –CO2−). All five carbons are 13C-enriched and the nitrogen is 15N-enriched, enabling sensitive tracing by NMR and MS.
Synthetic Utility
L-Glutamic acid-13C5,15N is a versatile isotopically labeled chiral building block for synthesis and labeling of peptides, small molecules, and polymers.
Key functional groups:
α-Amino (nucleophilic when deprotected) and two carboxyls (electrophilic as activated esters or acid chlorides). The γ-carboxyl provides a handle for side-chain modifications and conjugations.
Protecting-group strategies (general):
SPPS: Fmoc/tBu orthogonal protection (e.g., Fmoc-L-Glu(OtBu)-OH) with label retained on backbone; global deprotection with TFA.
Solution-phase: Boc for N-terminus; benzyl/tBu esters for carboxyls; hydrogenolysis or acidolysis for deprotection.
Conjugation chemistry:
Formation of amide linkages via HATU/HBTU/EDC·HCl or DIC/Oxyma. Side-chain selective coupling enables γ-amide formation for linkers, PROTAC-like spacers, or dendrimers.
Activation to NHS esters for bioconjugation to amines on proteins or surfaces; isotope label transfers intact.
Labeled scaffolds:
Incorporation into peptides/proteins enables site-specific 13C/15N NMR assignments (e.g., residue-selective labeling) and MS-based turnover studies.
Retrosynthetic value:
Serves as a labeled precursor to α-ketoglutarate (via oxidative deamination), GABA (via decarboxylation), or pyroglutamate derivatives (cyclization), providing isotopically defined standards.
Notes:
Maintain stereointegrity (L, S) by avoiding racemizing conditions (strong base, high temperature, prolonged activation). Monitor by chiral HPLC.
Confirm isotopic fidelity after multistep synthesis by HRMS and, when needed, 13C/15N NMR.
Target Specificity
Not applicable. This product is a small-molecule amino acid tracer, not an affinity reagent or antibody. No antigen/epitope, clone, or species reactivity applies.
Häufig gestellte Fragen
What is the purity of this product?
This product is isotopically enriched to ≥98 atom% carbon-13. Isotopic enrichment is a separate specification from chemical purity — a labelled compound has both. This product is isotopically enriched to ≥98 atom% nitrogen-15. Isotopic enrichment is a separate specification from chemical purity — a labelled compound has both. This product is supplied at ≥95% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at room temperature.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 202468-31-3, the molecular formula is (13C)5H9(15N)O4, and the molecular weight is 153.09 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Wir verwenden Cookies, um die ordnungsgemäße Funktion der Website sicherzustellen und, soweit zulässig, Ihr Nutzererlebnis zu verbessern. Sie können Ihre Einstellungen jederzeit unter „Einstellungen“ verwalten. Weitere Informationen finden Sie in unserer Cookie-Richtlinie.
Dürfen wir Sie über Rabattaktionen informieren?
Später erinnern
Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.